EQR

Quick Overview of Equity Residential

More and more people are talking about Equity Residential over the last few weeks. Is it worth buying the Specialty Real Estate Investment Trust stock at a price of $60.72? Only time will tell. The information below will give you a basic idea of what this investment may entail:

  • Equity Residential has moved 4.0% over the last year, and the S&P 500 logged a change of 22.9%

  • EQR has an average analyst rating of hold and is -4.59% away from its mean target price of $63.64 per share

  • Its trailing earnings per share (EPS) is $1.74

  • Equity Residential has a trailing 12 month Price to Earnings (P/E) ratio of 34.9 while the S&P 500 average is 15.97

  • Its forward earnings per share (EPS) is $1.57 and its forward P/E ratio is 38.7

  • The company has a Price to Book (P/B) ratio of 2.09 in contrast to the S&P 500's average ratio of 2.95

  • Equity Residential is part of the Real Estate sector, which has an average P/E ratio of 25.55 and an average P/B of 2.1

  • EQR has reported YOY quarterly earnings growth of -47.1% and gross profit margins of 0.6%

  • The company has a free cash flow of $1.3 Billion, which refers to the total sum of all its inflows and outflows of cash over the last quarter

  • Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract affluent long-term renters. Equity Residential owns or has investments in 305 properties consisting of 80,683 apartment units, with an established presence in Boston, New York, Washington, D.C., Seattle, San Francisco and Southern California, and an expanding presence in Denver, Atlanta, Dallas/Ft. Worth and Austin.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS